Skip to main content

Table 3 Comparative analysis of clinical characteristics and prognostic factors in patients with lymph node or bone marrow involvement

From: Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: A prospective observational study

 

LNi- (n = 75)

LNi+ (n = 29)

 

BMi- (n = 81)

BMi+ (n = 23)

 

Age, y

57.4

50.8

P = 0.003

53.6

62.4

p = 0.007

Tumor size, cm

1.88

2.16

ns

1.97

1.88

ns

Location

      

External quadrants

68%

65%

ns

73%

48%

 

Internal quadrants

32%

35%

 

27%

52%

p = 0.045

Radiological presentation

      

Nodule

71%

76%

ns

67%

91%

 

Microcalcification or distortion

29%

24%

 

33%

9%

p = 0.04

Histological type

      

Ductal infiltration

85%

90%

ns

87%

87%

 

No ductal infiltration

15%

10%

 

13%

13%

ns

Tumor grade

      

I

27%

12%

ns

23%

22%

 

II-III

73%

88%

 

77%

78%

ns

Lymphovascular invasion

11%

21%

ns

13%

13%

ns

Positive estrogen receptor status

70%

70%

ns

69%

76%

ns

Positive progesterone receptor status

59%

63%

ns

58%

67%

ns

Positive Erb-B2 receptor status

33%

19%

ns

28%

30%

ns

  1. Abbreviations: LNi, lymph node involvement; BMi, bone marrow involvement; ns, nonsignificant